SCHEMBL10074746

SCHEMBL10074746

CCC1CSSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL347594 0.79
SCHEMBL22300894 0.73
SCHEMBL1862796 0.73
SCHEMBL14375669 0.69
SCHEMBL22582769 0.67 ALDH1A1 (0.46)
SCHEMBL23637950 0.65
SCHEMBL2150283 0.65 ALDH1A1 (0.37)
SCHEMBL43433 0.65
SCHEMBL2222242 0.65 ALDH1A1 (0.37)
SCHEMBL2443414 0.65 NOS3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020154917-A1 PHOSPHATE AND PHOSPHONATE BASED COMPOUNDS OF 6-THIO-2'-DEOXYGUANOSINE AS ANTI-CANCER AGENTS MINGHUI PHARMACEUTICAL (SHANGHAI) LIMITED (CN) 2020-08-06 WO disclosed
US-20180208564-A1 1,2-DITHIOLANE AND DITHIOL COMPOUNDS USEFUL IN TREATING MUTANT EGFR-MEDIATED DISEASES AND CONDITIONS SABILA BIOSCIENCES LLC (US) 2018-07-26 US disclosed
US-20180208584-A1 1,2-DITHIOLANE AND DITHIOL COMPOUNDS USEFUL IN TREATING MUTANT EGFR-MEDIATED DISEASES AND CONDITIONS SABILA BIOSCIENCES LLC (US) 2018-07-26 US disclosed
US-9944630-B1 Dithiolane carbonate monomers and polymers thereof THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2018-04-17 US disclosed
WO-2014164200-A1 TYROSINASE INHIBITORS AVON PRODUCTS, INC (US) 2014-10-09 WO disclosed
WO-2014164195-A1 TYROSINASE INHIBITORS AVON PRODUCTS, INC (US) 2014-10-09 WO disclosed
US-8394427-B2 Paxillin stimulating compositions and cosmetic uses thereof AVON PRODUCTS, INC. (US) 2013-03-12 US disclosed
US-20120328546-A1 Paxillin Stimulating Compositions and Cosmetic Uses Thereof AVON PRODUCTS, INC. (US) 2012-12-27 US disclosed
US-8168212-B2 Topical compositions comprising non-proteogenic amino acids and methods of treating skin AVON PRODUCTS, INC (US) 2012-05-01 US disclosed
US-20110151029-A1 Paxillin Stimulating Compositions and Cosmetic Uses Thereof AVON PRODUCTS, INC. (US) 2011-06-23 US disclosed
US-20100261769-A1 Topical Compositions Comprising Non-Proteogenic Amino Acids and Methods of Treating Skin AVON PRODUCTS, INC. (US) 2010-10-14 US disclosed